gatifloxacin has been researched along with Pelvic Inflammatory Disease in 1 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Pelvic Inflammatory Disease: A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus (ENDOMETRITIS), the FALLOPIAN TUBES; (SALPINGITIS); the ovaries (OOPHORITIS), the supporting ligaments (PARAMETRITIS), or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility.
| Excerpt | Relevance | Reference |
|---|---|---|
| " To consider the optimized administration method based on PK/PD theory for gatifloxacin (GFLX), which was one of the oral fluoroquinolone antibacterial, we influenzae investigated clinical efficacies and adverse events for pelvic inflammatory disease (PID) in giving GFLX daily 400 mg divided twice a day or four times a day." | 3.73 | [Clinical investigation on administration method of gatifloxacin based on PK/PD theory]. ( Izumi, K; Mikamo, H; Tamaya, T; Tanaka, K; Watanabe, K, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikamo, H | 1 |
| Tanaka, K | 1 |
| Watanabe, K | 1 |
| Tamaya, T | 1 |
| Izumi, K | 1 |
1 other study available for gatifloxacin and Pelvic Inflammatory Disease
| Article | Year |
|---|---|
[Clinical investigation on administration method of gatifloxacin based on PK/PD theory].
Topics: Anti-Infective Agents; Escherichia coli; Female; Fluoroquinolones; Gatifloxacin; Humans; Pelvic Infl | 2006 |